Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB26FX3SD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,270
Award facts
- Contract value 100% obligated
- $55,269.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,269.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. CIMZIA is a biologic immunosuppressant used to treat inflammatory conditions, and this delivery order fulfills medical supply requirements for the Defense Health Agency and other federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has demonstrated consistent capability in supporting federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA. The company supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems worldwide. As a prime vendor under the DLA Troop Support Medical IDC, AmerisourceBergen has established itself as a critical logistics partner for the federal government's pharmaceutical supply chain, enabling flexible and efficient delivery of essential medical products to support military readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX3SD?
SPE2DB26FX3SD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FX3SD worth?
The government has obligated $55,270 on SPE2DB26FX3SD.
Is contract SPE2DB26FX3SD an order under another contract?
Yes. SPE2DB26FX3SD is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3SD competed?
The extent of competition for SPE2DB26FX3SD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award